Vertex Pharmaceuticals Shares Gain After FDA Approves Non-Opioid Pain Drug
In This Article:
Shares of Vertex Pharmaceuticals rose after Journavx, the company’s oral non-opioid pain medication, received Food and Drug Administration approval.
Terms and Privacy Policy